Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Teva Pharma Ind.       

TEVA PHARMA IND.
My previous session
Most popular
  Report  
 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Financials (USD)
More Financials
Company
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which engages in development, production and marketing of drugs, generic drugs, over-the-counter drugs, active ingredients for the pharmaceutical industry (APIs) and therapeutic products.It operates through two segments:... 
Sector
Pharmaceuticals
Calendar
11/01 | 12:00pmEarnings Release
More about the company
Latest news on TEVA PHARMA IND.
10/12MYLAN : Gets Favorable Appeals Court Ruling in Patent Dispute Over Teva's Copaxo..
DJ
10/11TEVA PHARMACEUTICAL INDUSTRIES : Draws on Patient Experience to Empower Those Li..
BU
10/11CELLTRION : FDA panel votes in favor of Celltrion's rituximab biosimilar
AQ
10/10TEVA PHARMACEUTICAL INDUSTRIES : Says Long-Range Study of Copaxone Shows 'Accept..
DJ
10/10TEVA PHARMACEUTICAL INDUSTRIES : Celltrion and Teva Announce FDA Oncologic Drugs..
BU
10/10TEVA PHARMACEUTICAL INDUSTRIES : to Report Third Quarter 2018 Financial Results ..
AQ
10/10TEVA PHARMACEUTICAL INDUSTRIES : Presents 25-year Safety Data from Longest Conti..
BU
10/10TEVA PHARMACEUTICAL INDUSTRIES : Celmatix partners with Oncotest-Teva to bring F..
AQ
10/08TEVA PHARMACEUTICAL INDUSTRIES : to Present New Data at 34th European Committee ..
BU
10/05TEVA PHARMACEUTICAL INDUSTRIES : to Report Third Quarter 2018 Financial Results ..
BU
More news
Sector news : Pharmaceuticals - NEC
10/19FDA Approves Asthma Indication for Regeneron and Sanofi's Dupixent
DJ
10/19ABBVIE : CFO Chase to retire by mid-year 2019
RE
10/19MYLAN : Launches Hulio, a Biosimilar to Humira, in Europe
DJ
10/19FDA Approves Label Update for Genentech's Rituxan
DJ
10/19ABBVIE : Chief Financial Officer Chase to Retire; Michael Takes Post
DJ
More sector news : Pharmaceuticals - NEC
Chart TEVA PHARMA IND.
Duration : Period :
Teva Pharma Ind. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 26,0 $
Spread / Average Target 20%
Managers
NameTitle
Kåre Schultz President, Chief Executive Officer & Director
Sol J. Barer Chairman
Carlo de Notaristefani Executive Vice President-Global Operations
Michael McClellan Chief Financial Officer & Executive Vice President
Amir Elstein Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMA IND.0.00%22 174
JOHNSON & JOHNSON-4.19%374 244
PFIZER20.87%257 933
NOVARTIS0.07%220 104
ROCHE HOLDING LTD.-4.56%206 610
MERCK AND COMPANY23.44%192 044